Table II.
Study group (n = 94) |
Grade IV at onset (n = 68) |
Grade V at onset (n = 26) |
|||||||
---|---|---|---|---|---|---|---|---|---|
Variable | Change difference* |
95% CI | p | Change difference* |
95% CI | p | Change difference* |
95% CI | p |
Kabat | -0.99 | -1.27, -0.71 | < 0.001 | -0.86 | -1.23, -0.49 | < 0.001 | -1.10 | -1.82, -0.38 | 0.005 |
10-years increase in age | 0.05 | -0.03, 0.13 | 0.206 | 57.1% | 0.01, 0.17 | 0.029 | -0.06 | -0.29, 0.16 | 0.56 |
Male | -0.02 | 0.888 | 64.3% | -0.32, 0.21 | 0.698 | 0.08 | -0.58, 0.74 | 0.80 |
Negative values indicate improvement, i.e. decrease in grade * All patients who had an improvement by three grades or more were treated with Kabat.